Back to search
FDAFDA · Food and drugs·Recall number D-219-2013

TORISEL Kit (temsirolimus) injection, 25 mg/mL, CONCENTRATED, Rx Only, Packaged in a carton containing 1 vial TORISEL injection and 1 vial DILUENT for TORISEL, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA --- NDC 0008-1179-01

Published April 3, 2013 · Recall initiated: November 26, 2012

Summary

FDA records drug Class III recall D-219-2013, published April 3, 2013 and initiated November 26, 2012. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 10920 kits; Lot: Lots P00025A; P00027B. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials.

What to do

Voluntary: Firm initiated · Letter

Get an email if TORISEL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TORISEL
Manufacturer
Pfizer Inc.
Distributor
Nationwide
Lot
Lots P00025A; P00027B
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was TORISEL Kit (temsirolimus) injection, 25 mg/mL, CONCENTRATED, Rx Only, Packaged in a carton containing 1 vial TORISEL injection and 1 vial DILUENT for TORISEL, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA --- NDC 0008-1179-01 recalled?

Yes. FDA published recall D-219-2013 on April 3, 2013. Reported hazard: Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TORISEL.